Group of Neurochemistry for Parkinson's Disease, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Santiago de Compostela, San Francisco 1, 15782 Santiago de Compostela, Spain.
Neurochem Res. 2012 Oct;37(10):2150-60. doi: 10.1007/s11064-012-0838-6. Epub 2012 Jul 22.
Oxidative stress and mitochondrial dysfunction are two pathophysiological factors often associated with the neurodegenerative process involved in Parkinson's disease (PD). Although, 6-hydroxydopamine (6-OHDA) is able to cause dopaminergic neurodegeneration in experimental models of PD by an oxidative stress-mediated process, the underlying molecular mechanism remains unclear. It has been established that some antioxidant enzymes such as catalase (CAT) and superoxide dismutase (SOD) are often altered in PD, which suggests a potential role of these enzymes in the onset and/or development of this multifactorial syndrome. In this study we have used high-resolution respirometry to evaluate the effect of 6-OHDA on mitochondrial respiration of isolated rat brain mitochondria and the lactate dehydrogenase cytotoxicity assay to assess the percentage of cell death induced by 6-OHDA in human neuroblastoma cell line SH-SY5Y. Our results show that 6-OHDA affects mitochondrial respiration by causing a reduction in both respiratory control ratio (IC(50) = 200 ± 15 nM) and state 3 respiration (IC(50) = 192 ± 17 nM), with no significant effects on state 4(o). An inhibition in the activity of both complex I and V was also observed. 6-OHDA also caused cellular death in human neuroblastoma SH-SY5Y cells (IC(50) = 100 ± 9 μM). Both SOD and CAT have been shown to protect against the toxic effects caused by 6-OHDA on mitochondrial respiration. However, whereas SOD protects against 6-OHDA-induced cellular death, CAT enhances its cytotoxicity. The here reported data suggest that both superoxide anion and hydroperoxyl radical could account for 6-OHDA toxicity. Furthermore, factors reducing the rate of 6-OHDA autoxidation to its p-quinone appear to enhance its cytotoxicity.
氧化应激和线粒体功能障碍是两种与帕金森病(PD)相关的神经退行性过程的病理生理因素。虽然 6-羟多巴胺(6-OHDA)能够通过氧化应激介导的过程在 PD 的实验模型中引起多巴胺能神经退行性变,但潜在的分子机制尚不清楚。已经确定一些抗氧化酶,如过氧化氢酶(CAT)和超氧化物歧化酶(SOD),在 PD 中经常发生改变,这表明这些酶在这种多因素综合征的发生和/或发展中可能具有潜在作用。在这项研究中,我们使用高分辨率呼吸测定法来评估 6-OHDA 对分离的大鼠脑线粒体线粒体呼吸的影响,以及乳酸脱氢酶细胞毒性测定法来评估 6-OHDA 在人神经母细胞瘤 SH-SY5Y 细胞系中诱导的细胞死亡百分比。我们的结果表明,6-OHDA 通过降低呼吸控制比(IC(50)= 200±15 nM)和状态 3 呼吸(IC(50)= 192±17 nM)来影响线粒体呼吸,对状态 4(o)没有显著影响。还观察到对复合物 I 和 V 的活性抑制。6-OHDA 还导致人神经母细胞瘤 SH-SY5Y 细胞的细胞死亡(IC(50)= 100±9 μM)。SOD 和 CAT 均已被证明可防止 6-OHDA 对线粒体呼吸的毒性作用。然而,SOD 可防止 6-OHDA 诱导的细胞死亡,而 CAT 则增强其细胞毒性。这里报道的数据表明,超氧阴离子和过氧自由基都可能导致 6-OHDA 的毒性。此外,降低 6-OHDA 自动氧化为其对醌的速率的因素似乎增强了其细胞毒性。